EP0810853B1
(de)
*
|
1995-02-24 |
2004-08-25 |
Elan Pharma International Limited |
Nanopartikel-dispersionen enthaltende aerosole
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
CN1245955C
(zh)
|
1998-05-29 |
2006-03-22 |
斯凯伊药品加拿大公司 |
热保护微粒组合物及其最终蒸汽灭菌的方法
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
NZ511442A
(en)
|
1998-11-02 |
2003-02-28 |
Elan Corp Plc |
Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
KR20010073232A
(ko)
|
1998-11-20 |
2001-07-31 |
추후제출 |
분산성 인지질로 안정화된 마이크로입자
|
ES2241663T3
(es)
*
|
1999-09-21 |
2005-11-01 |
Skyepharma Canada Inc. |
Composiciones particuladas modificadas superficialmente de substancias biologicamente activas.
|
US6770478B2
(en)
*
|
2000-02-10 |
2004-08-03 |
The Regents Of The University Of California |
Erythrocytic cells and method for preserving cells
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US7053092B2
(en)
|
2001-01-29 |
2006-05-30 |
Otsuka Pharmaceutical Co., Ltd. |
5-HT1a receptor subtype agonist
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
PT1389462E
(pt)
*
|
2001-04-26 |
2012-06-19 |
Meiji Seika Pharma Co Ltd |
Composição de cefditoreno pivoxil amorfo e processo para o produzir
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
WO2003000228A2
(en)
*
|
2001-06-22 |
2003-01-03 |
Elan Pharma International Ltd. |
Method for high through put screening using a small scale mill or microfluidics
|
US7758890B2
(en)
*
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
DE60220923T2
(de)
*
|
2001-08-06 |
2008-03-06 |
Astrazeneca Ab |
Wässrige dispersion stabiler nanopartikel eines wasserunlöslichen wirkstoffs und ein hilfsstoff wie mittelkettige triglyceride (mct)
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
PT1429731E
(pt)
*
|
2001-09-19 |
2007-04-30 |
Elan Pharma Int Ltd |
Formulações de insulina nanoparticulada
|
US8703772B2
(en)
|
2001-09-25 |
2014-04-22 |
Otsuka Pharmaceutical Co., Ltd. |
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
|
AR033485A1
(es)
|
2001-09-25 |
2003-12-26 |
Otsuka Pharma Co Ltd |
Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
|
EP1429749A2
(de)
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Herstellung von nanopartikeln im submikrometerbereich durch dispersion und entzug des lösungsmittels oder der flüssigen phase
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
DE60222160T2
(de)
*
|
2001-10-12 |
2008-06-12 |
Elan Pharma International Ltd., Athlone |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
US20030087837A1
(en)
*
|
2001-10-15 |
2003-05-08 |
Jonas Jeffrey M. |
Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
UA76810C2
(uk)
*
|
2001-12-10 |
2006-09-15 |
Мерк Енд Ко., Інк. |
Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
AU2003210517A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
EP1490030B2
(de)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
EP1800666A1
(de)
*
|
2002-03-20 |
2007-06-27 |
Elan Pharma International Limited |
Nanopartikelzusammensetzungen von Angiogeneseinhibitoren
|
ES2380318T3
(es)
|
2002-04-12 |
2012-05-10 |
Alkermes Pharma Ireland Limited |
Formulaciones nanoparticulares de megestrol
|
US9101540B2
(en)
*
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
EP1503737B1
(de)
*
|
2002-05-06 |
2009-01-07 |
Elan Pharma International Limited |
Nystatin-nanopartikelzusammensetzungen
|
WO2003103632A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
JP4776229B2
(ja)
*
|
2002-07-16 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
安定なナノ粒子活性物質の液体投与組成物
|
DK1553927T3
(da)
|
2002-09-11 |
2011-01-31 |
Elan Pharma Int Ltd |
Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
|
CA2500908A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
ES2365012T3
(es)
*
|
2002-11-12 |
2011-09-20 |
Elan Pharma International Limited |
Formas farmacéuticas sólidas de desintegración rápida que no son friables y que comprenden pululano.
|
CN1243538C
(zh)
*
|
2002-11-21 |
2006-03-01 |
武汉利元亨药物技术有限公司 |
熊果酸豆磷脂纳米粒冻干粉针及制备方法
|
WO2004058216A2
(en)
*
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
JP4469846B2
(ja)
*
|
2003-01-31 |
2010-06-02 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子状トピラメート製剤
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
EP1626742A1
(de)
*
|
2003-05-22 |
2006-02-22 |
Elan Pharma International Limited |
Sterilisierung von dispersionen von nanopartikulären aktiven stoffen mittels gamma-strahlung
|
US20050042177A1
(en)
*
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
ATE415946T1
(de)
*
|
2003-08-08 |
2008-12-15 |
Elan Pharma Int Ltd |
Neue metaxalon-zusammensetzungen
|
SG135189A1
(en)
*
|
2003-09-22 |
2007-09-28 |
Baxter Int |
High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
|
CN1870980B
(zh)
*
|
2003-10-23 |
2010-06-23 |
大冢制药株式会社 |
控释无菌阿立哌唑注射剂和方法
|
TWI371274B
(en)
|
2003-10-23 |
2012-09-01 |
Bristol Myers Squibb Co |
Process for making sterile aripiprazole of desired mean particle size
|
ES2366646T3
(es)
*
|
2003-11-05 |
2011-10-24 |
Elan Pharma International Limited |
Composiciones en forma de nanopartículas que tienen un péptido como estabilizante superficial.
|
WO2005077337A2
(en)
*
|
2004-02-05 |
2005-08-25 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
GB0410995D0
(en)
|
2004-05-17 |
2004-06-23 |
Norton Healthcare Ltd |
Heat sterilization of glucocorticosteroids
|
US20060083694A1
(en)
|
2004-08-07 |
2006-04-20 |
Cabot Corporation |
Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
|
WO2006083326A2
(en)
*
|
2004-08-07 |
2006-08-10 |
Cabot Corporation |
Gas dispersion manufacture of nanoparticulates and nanoparticulate-containing products and processing thereof
|
KR20070043894A
(ko)
*
|
2004-08-19 |
2007-04-25 |
알자 코포레이션 |
제어 방출형 나노입자 활성제 제제 제형 및 방법
|
JP5324098B2
(ja)
*
|
2004-11-16 |
2013-10-23 |
アルケルメス ファーマ アイルランド リミテッド |
注射可能なナノ粒子のオランザピン製剤
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
WO2006062875A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Merck & Co., Inc. |
Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
|
MX2007007342A
(es)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
WO2006069098A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Elan Pharma International Ltd. |
Nanoparticulate bicalutamide formulations
|
MX2007008212A
(es)
*
|
2005-01-06 |
2007-08-16 |
Elan Pharma Int Ltd |
Formulaciones de candesartan en nanoparticulas.
|
EP1853234A2
(de)
*
|
2005-02-15 |
2007-11-14 |
Elan Pharma International Limited |
Aerosol und injizierbare formulierungen aus benzodiazepin in form von nanoteilchen
|
WO2006096462A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of heterocyclic amide derivatives
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
BRPI0606283A2
(pt)
*
|
2005-03-16 |
2009-06-09 |
Elan Pharma Int Ltd |
formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
|
CN101198316A
(zh)
*
|
2005-03-17 |
2008-06-11 |
伊兰制药国际有限公司 |
纳米微粒双膦酸盐组合物
|
MX2007011772A
(es)
*
|
2005-03-23 |
2007-12-05 |
Elan Pharma Int Ltd |
Formulaciones de antihistaminico y corticosteroide de materia en nanoparticulas.
|
JP2008535921A
(ja)
|
2005-04-12 |
2008-09-04 |
エラン・ファルマ・インターナショナル・リミテッド |
シクロスポリンを含むナノ粒子および放出調節された組成物
|
BRPI0607537A2
(pt)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
WO2006109177A1
(en)
*
|
2005-04-13 |
2006-10-19 |
Pfizer Products Inc. |
Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles
|
US20080305161A1
(en)
*
|
2005-04-13 |
2008-12-11 |
Pfizer Inc |
Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
|
BRPI0609299A2
(pt)
*
|
2005-04-13 |
2010-03-23 |
Pfizer Prod Inc |
formulaÇÕes de depàsito injetÁveis e mÉtodos para proporcionar liberaÇço sustentada de composiÇÕes de nanopartÍculas
|
CA2607494A1
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel formulations
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
AU2006309295B2
(en)
*
|
2005-06-03 |
2012-04-26 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
CA2610448A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate imatinib mesylate formulations
|
WO2008073068A1
(en)
|
2005-06-08 |
2008-06-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cefditoren
|
EP1898882B1
(de)
*
|
2005-06-09 |
2009-10-28 |
Elan Pharma International Limited |
Nanopartikuläre ebastinformulierungen
|
AU2006259606A1
(en)
*
|
2005-06-13 |
2006-12-28 |
Elan Pharma International, Limited |
Nanoparticulate clopidogrel and aspirin combination formulations
|
US20100221327A1
(en)
*
|
2005-06-15 |
2010-09-02 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
US20070015719A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International Limited |
Nanoparticulate clarithromycin formulations
|
US20080193534A1
(en)
*
|
2005-08-12 |
2008-08-14 |
Astrazeneca Ab |
Process
|
CA2621800A1
(en)
*
|
2005-09-06 |
2007-03-15 |
Astellas Pharma Inc. |
Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof
|
JP2009507925A
(ja)
*
|
2005-09-13 |
2009-02-26 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子タダラフィル製剤
|
US20070148100A1
(en)
*
|
2005-09-15 |
2007-06-28 |
Elan Pharma International, Limited |
Nanoparticulate aripiprazole formulations
|
WO2007041079A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Alza Corporation |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
ES2812250T3
(es)
*
|
2005-11-28 |
2021-03-16 |
Marinus Pharmaceuticals Inc |
Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
|
US10100266B2
(en)
|
2006-01-12 |
2018-10-16 |
The Board Of Trustees Of The University Of Arkansas |
Dielectric nanolubricant compositions
|
MX2008009032A
(es)
|
2006-01-12 |
2008-09-26 |
Univ Arkansas |
Composiciones de nanoparticulas y metodos para fabricarlas y utilizarlas.
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
AU2007224006A1
(en)
*
|
2006-03-07 |
2007-09-13 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
US20080166411A1
(en)
*
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
NZ573555A
(en)
*
|
2006-05-30 |
2012-09-28 |
Elan Pharma Int Ltd |
Nanoparticulate posaconazole formulations
|
WO2008002568A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
JP2009543797A
(ja)
*
|
2006-07-10 |
2009-12-10 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ソラフェニブ製剤
|
BRPI0714173A2
(pt)
*
|
2006-07-12 |
2012-12-25 |
Elan Pharma Int Ltd |
composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
|
EA019366B1
(ru)
*
|
2006-11-13 |
2014-03-31 |
Басф Се |
Применение блок-сополимеров на основе виниллактамов и винилацетата в качестве ингибиторов кристаллизации, препарат агрохимических компонентов, включающий поливиниллактам-поливинилацетатный блок-сополимер, способ борьбы с нежелательным нападением насекомых или клещей и/или борьбы с фитопатогенными грибами и способ борьбы с нежелательным ростом растений
|
BRPI0717721A2
(pt)
*
|
2006-11-28 |
2013-10-29 |
Marinus Pharmaceuticals |
"partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"
|
EP2109443A4
(de)
*
|
2007-02-09 |
2012-08-22 |
Astrazeneca Ab |
Verfahren zur herstellung einer stabilen dispersion aus festen amorphen submikron-partikeln in einem wässrigen medium
|
TW200848039A
(en)
*
|
2007-02-09 |
2008-12-16 |
Astrazeneca Ab |
Pharmaceutical compositions
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8974827B2
(en)
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
ES2661037T3
(es)
*
|
2007-07-31 |
2018-03-27 |
Otsuka Pharmaceutical Co., Ltd. |
Procedimientos para producir una suspensión de aripiprazol y una formulación liofilizada
|
WO2009049304A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Map Pharmaceuticals, Inc. |
Inhalation drug delivery
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
DK3045043T3
(da)
|
2009-02-26 |
2020-08-03 |
Relmada Therapeutics Inc |
Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
|
SG175137A1
(en)
*
|
2009-04-09 |
2011-11-28 |
Alkermes Pharma Ireland Ltd |
Drug delivery composition
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
WO2010138539A2
(en)
|
2009-05-27 |
2010-12-02 |
Elan Pharma International Ltd. |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
JP2015501802A
(ja)
|
2011-11-17 |
2015-01-19 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate |
眼への薬物送達を向上させるための方法および組成物、ならびに徐放性送達製剤
|
JP5900938B2
(ja)
|
2012-04-24 |
2016-04-06 |
国立大学法人大阪大学 |
薬剤ナノ粒子を分散した水分散液の製造法およびその利用
|
HUE050993T2
(hu)
|
2012-05-08 |
2021-01-28 |
Nicox Ophthalmics Inc |
Flutikazon-propionát polimorf formája
|
US8765725B2
(en)
|
2012-05-08 |
2014-07-01 |
Aciex Therapeutics, Inc. |
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
CN104583114B
(zh)
*
|
2012-06-18 |
2017-04-05 |
苏州诺菲纳米科技有限公司 |
储存于容器中的纳米线悬浮液的聚结物减少
|
US9251937B2
(en)
|
2012-06-29 |
2016-02-02 |
General Electric Company |
Heat stable nanoparticle preparations and associated methods thereof
|
US9815865B2
(en)
|
2013-01-07 |
2017-11-14 |
Nicox Ophthalmics, Inc. |
Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
|
JP6336246B2
(ja)
*
|
2013-03-13 |
2018-06-06 |
大同化成工業株式会社 |
ナノ粒子化製剤及びその製造方法
|
CN107001810A
(zh)
|
2014-12-15 |
2017-08-01 |
M技术株式会社 |
有机物微粒的制造方法及有机物微粒的改性方法
|
EP3288957A4
(de)
|
2015-05-01 |
2019-01-23 |
Cocrystal Pharma, Inc. |
Nukleosidanaloga zur behandlung von viren der flaviviidae-familie und krebs
|
WO2017066626A1
(en)
|
2015-10-16 |
2017-04-20 |
Marinus Pharmaceuticals, Inc. |
Injectable neurosteroid formulations containing nanoparticles
|
CN109715151A
(zh)
|
2016-08-11 |
2019-05-03 |
奥维德医疗公司 |
用于治疗癫痫性紊乱的方法和组合物
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
EP4009982A4
(de)
|
2019-08-05 |
2023-08-09 |
Marinus Pharmaceuticals, Inc. |
Ganaxolon zur verwendung bei der behandlung von status epilepticus
|
AU2020395254A1
(en)
|
2019-12-06 |
2022-06-02 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treating tuberous sclerosis complex
|
US11499081B2
(en)
|
2020-08-04 |
2022-11-15 |
Baker Hughes Oilfield Operations Llc |
Stabilized water-dispersible latex additives for drilling fluids
|